Early indicators, early treatments, neuroprotection in multiple sclerosis

Early diagnosis is a new challenge for the neurologist, as demonstrated by the advantages of early treatment of multiple sclerosis with interferon beta. The rationale for early treatment is extensively reviewed together with the mechanism underlying irreversible damage in MS.